NCT02368015View on ClinicalTrials.gov

Penetration of Cefazolin Into Hepatic Cysts

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

January 31, 2016

Conditions
Hepatic Cyst
Interventions
OTHER

Peripheral intravenous cannula (IVC)

Blood samples will be withdrawn prior, during and after the procedure using an additional peripheral intravenous cannula (IVC).

DRUG

cefazolin

Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Center; Department of Gastroenterology & Hepatology, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02368015 - Penetration of Cefazolin Into Hepatic Cysts | Biotech Hunter | Biotech Hunter